Pharsight

Drug patents revoked in 2022

Drug patents revoked in 2022 at the European Patent Office (EPO).

Patent Number Patent Title Company Revoked Date Oppositions
EP3107627B1 Skin cleansing compositions comprising biodegradable abrasive particles PROCTER AND GAMBLE CO Dec, 2022
(Expiration: Feb, 2035)
BEIERSDORF
HENKEL
EP2376535B9 Anti-pd-l1 antibodies and their use to enhance t-cell function F HOFFMANN LA ROCHE AG Dec, 2022
(Expiration: Dec, 2029)
FURO VENTURES
EP2687106B1 High energy liquid enteral nutritional composition NUTRICIA NV Dec, 2022
(Expiration: Dec, 2028)
EVEN SANTE INDUSTRIE
FRESENIUS KABI DEUTSCHLAND
NESTEC
EP2603100B1 Dry storage stabilizing composition for biological materials ADVANCED BIONUTRTION CORP Dec, 2022
(Expiration: Aug, 2031)
CHR HANSEN
EP2676967B1 Methods of treating inflammatory and autoimmune diseases with natalizumab BIOGEN MA INC Dec, 2022
(Expiration: Feb, 2027)
POLPHARMA BIOLOGICS
EP2978451B1 Compositions and methods for increasing the serum half-life of a therapeutic agent targeting complement c5 ALEXION PHARMACEUTICALS INC Dec, 2022
(Expiration: Mar, 2034)
ALNYLAM PHARMACEUTICALS
REGENERON PHARMACEUTICALS
EP2403947B1 Method for the oral/mucosal vaccination by means of recombinant yeasts MARTIN LUTHER UNIVERSITAET HALLE WITTENBERG Nov, 2022
(Expiration: Nov, 2029)
OETKE
EP2581097B1 Compositions for prevention of adhesions and other barrier applications ARCH BIOSURGERY INC Nov, 2022
(Expiration: Apr, 2028)
STRAWMAN
EP2437762B1 Artificial tears and therapeutic uses ALLERGAN INC Nov, 2022
(Expiration: Jun, 2030)
JOHNSON & JOHNSON VISION CARE
EP2704742B1 Formulation for anti- 4 7 antibody MILLENNIUM PHARMACEUTICALS INC Nov, 2022
(Expiration: May, 2032)
DEHMEL & BETTENHAUSEN
GILL JENNINGS & EVERY
EP3057612B1 Method of obtaining thermostable dried vaccine formulations MERCK SHARP AND DOHME LLC Nov, 2022
(Expiration: Oct, 2034)
GLAXO GROUP
EP2526963B1 Stabilized Antibody-Containing Liquid Formulations CHUGAI PHARMACEUTICAL CO LTD Nov, 2022
(Expiration: Jan, 2031)
HEXAL SANDOZ
EP2885395B1 Method for freeze drying a bacteria-containing concentrate CHR HANSEN AS Nov, 2022
(Expiration: Aug, 2033)
DSM ASSETS
GEA PROCESS ENGINEERING
STRAWMAN
EP2692359B1 Cancer immunopotienting agent containing rankl antagonist ORIENTAL YEAST CO LTD Nov, 2022
(Expiration: Mar, 2032)
DEHMEL & BETTENHAUSEN
EP2283818B1 Method of making particles for use in a pharmaceutical composition VECTURA LTD Nov, 2022
(Expiration: Nov, 2021)
GLAXO GROUP
EP2271218B1 Use and composition for treating dementia CHASE PHARMACEUTICALS CORP Nov, 2022
(Expiration: Mar, 2029)
HEXAL
EP3136861B1 Composition containing peroxide and an antimicrobial agent and process of killing spores AMERICAN STERILIZER CO Nov, 2022
(Expiration: Feb, 2035)
BODE CHEMIE
EP3078375B1 Anti-fatigue composition AJINOMOTO CO INC Nov, 2022
(Expiration: Oct, 2034)
NUTRICIA
EP3359561B1 Modulators of complement function INDIVIDUAL Nov, 2022
(Expiration: Dec, 2036)
ALGEMEEN OCTROOI EN MERKENBUREAU
EP2708548B1 High-Purity Rebaudioside D and Applications PURECIRCLE SDN BHD Nov, 2022
(Expiration: Oct, 2030)
JACOBACCI & PARTNERS
RUSSELL
EP3437645B1 Film-coated tablet having high chemical stability of active ingredient INTERCEPT PHARMACEUTICALS INC Nov, 2022
(Expiration: Mar, 2037)
SANDOZ
EP2285410B1 Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation BOEHRINGER INGELHEIM INTERNATIONAL GMBH Nov, 2022
(Expiration: Apr, 2029)
GALENICUM HEALTH SLU
HEXAL
HGF
ISARPATENT PATENT UND RECHTSANWLTE BEHNISCH BARTH CHARLES HASSA PECKMANN UND PARTNER MBB
EP1145706B1 Composition particularly for cosmetics comprising ascorbic acid in combination with an ascorbic acid derivative LOREAL SA Oct, 2022
(Expiration: Mar, 2021)
BEIERSDORF
EP3233258B1 Two-component products in bags for the oxidative dyeing of keratin fibres HENKEL AG AND CO KGAA Oct, 2022
(Expiration: Nov, 2035)
HAMMER
EP2800469B1 Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject AMARIN PHARMACEUTICALS IRELAND LTD Oct, 2022
(Expiration: Jan, 2033)
COOKE
ELKINGTON AND FIFE
EP3308836B1 Octocrylene-free, odour-stable sun protection agent BEIERSDORF AG Oct, 2022
(Expiration: Jun, 2034)
BASF
EMIL KIESSLING
LOREAL
EP2450437B1 Gene defects and mutant ALK kinase in human solid tumors CELL SIGNALING TECHNOLOGY INC Oct, 2022
(Expiration: Apr, 2027)
F HOFFMANN LA ROCHE
EP2349321B1 Annexin and its use to treat inflammatory disorders LONDON HEALTH SCIENCES CENTRE RESEARCH INC Oct, 2022
(Expiration: Oct, 2029)
STRAWMAN
EP2618819B1 Pharmaceutical formulations containing rifaximin, processes for their obtainment and method of treating intestinal disease ALFASIGMA SPA Oct, 2022
(Expiration: Sep, 2031)
SANDOZ
EP2708147B1 Methods for increasing brain functionality using 2-fucosyl-lactose ABBOTT LABORATORIES Oct, 2022
(Expiration: Sep, 2032)
NUTRICIA
RECKITT BENCKISER HEALTH
SOCIT DES PRODUITS NESTL
EP3076969B1 Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor NOVARTIS AG Oct, 2022
(Expiration: Dec, 2034)
ELKINGTON AND FIFE
EP3215130B1 Pharmaceutical composition comprising bisoprolol and perindoril LABORATOIRES SERVIER SAS Oct, 2022
(Expiration: Nov, 2035)
KRKA
EP2809773B1 Process of modulating man5 and/or afucosylation content of glycoprotein composition DR REDDYS LABORATORIES LTD Oct, 2022
(Expiration: Jan, 2033)
BREUER
D YOUNG
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
OETKE
STRAWMAN
EP3093295B1 Il-15 heterogeneous dimer protein and uses thereof JIANGSU HENGRUI MEDICINE CO LTD Oct, 2022
(Expiration: Dec, 2034)
MARGARET DIXON
EP3395339B8 Rapid dissolution formulation of a cinacalcet hcl AMGEN INC Oct, 2022
(Expiration: Sep, 2024)
ACCORD HEALTHCARE
AECHTER
BETAPHARM ARZNEIMITTEL
BIOGARAN
GILLARD
GLENMARK PHARMACEUTICALS EUROPE
HEXAL
HGF
MAIWALD PATENTANWALTS UND RECHTSANWALTSGESELLSCHAFT
TEVA PHARMACEUTICAL INDUSTRIES
ZENTIVA
EP2206728B9 Methods for treating bone cancer pain by administering a nerve growth factor antagonistic antibody UNIVERSITY OF MINNESOTA Oct, 2022
(Expiration: Apr, 2025)
REGENERON PHARMACEUTICALS
EP3319622B1 Method for producing rna molecule compositions CUREVAC AG Oct, 2022
(Expiration: Dec, 2036)
BIONTECH RNA PHARMACEUTICALS
EP3003330B1 Microbiota restoration therapy (mrt), compositions and methods of manufacture REBIOTIX INC Oct, 2022
(Expiration: Jun, 2034)
STRAWMAN
EP1957110B8 Process for manufacturing chewable dosage forms for drug delivery and products thereof BAYER HEALTHCARE LLC Sep, 2022
(Expiration: Dec, 2026)
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
EP2705849B1 A preparation for use of aspartate for regulating glucose levels in blood NUTRICIA NV Sep, 2022
(Expiration: Jul, 2025)
FRESENIUS KABI DEUTSCHLAND
EP2337472B1 A cosmetic or dermatological system with automatic adjustment of the properties of a preparation as a function of data transmitted by a transmitter external to the system LOREAL SA Sep, 2022
(Expiration: Oct, 2029)
HENKEL
STRAWMAN
EP2506850B1 Methods of administering pirfenidone therapy INTERMUNE INC Sep, 2022
(Expiration: Dec, 2030)
AERA
ALFRED E TIEFENBACHER
GENERICS UK
INTAS PHARMACEUTICALS
SANDOZ
STADA ARZNEIMITTEL
EP2596786B1 Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia AMARIN PHARMACEUTICALS IRELAND LTD Sep, 2022
(Expiration: Feb, 2030)
ELKINGTON AND FIFE
HOFFMANN EITLE
EP3037089B1 Eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia AMARIN PHARMACEUTICALS IRELAND LTD Sep, 2022
(Expiration: Feb, 2030)
ELKINGTON AND FIFE
HOFFMANN EITLE
EP3328198B1 Preservative system based on organic acids COLGATE PALMOLIVE CO Sep, 2022
(Expiration: Aug, 2035)
HENKEL
EP3294285B1 Cabazitaxel and its use for treating cancer SANOFI MATURE IP Sep, 2022
(Expiration: May, 2036)
ACCORD HEALTHCARE
DR REDDYS LABORATORIES BETAPHARM ARZNEIMITTEL
FRESENIUS KABI DEUTSCHLAND
GENERICS UK
HEXAL
MEDAC GESELLSCHAFT FR KLINISCHE SPEZIALPRPARATE
STADA ARZNEIMITTEL
TEVA PHARMACEUTICAL INDUSTRIES
ZENTIVA
EP2585075B8 Methods of treatment for esophageal inflammation VIROPHARMA BIOLOGICS LLC Sep, 2022
(Expiration: Jun, 2031)
DR FALK PHARMA
EP2887961B1 Nep inhibitors for treating diseases characterized by atrial enlargement or remodeling NOVARTIS AG Sep, 2022
(Expiration: Aug, 2033)
ALFRED E TIEFENBACHER
ALGEMEEN OCTROOI EN MERKENBUREAU
GENERICS UK
STADA ARZNEIMITTEL
TEVA PHARMACEUTICAL INDUSTRIES
WUESTHOFF & WUESTHOFF PATENTANWLTE PARTG MBB
EP3028691B1 Ceramide dispersion composition FUJIFILM CORP Sep, 2022
(Expiration: Jun, 2034)
EVONIK INDUSTRIES
HENKEL
EP3370685B1 Cosmetic foam from an emulsion containing glycerin and alcohol BEIERSDORF AG Sep, 2022
(Expiration: Oct, 2036)
HENKEL
EP2504002B1 Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin BOEHRINGER INGELHEIM INTERNATIONAL GMBH Sep, 2022
(Expiration: Nov, 2030)
ELKINGTON AND FIFE
HEXAL
EP2832858B1 Method for producing steviol glycoside SUNTORY HOLDINGS LTD Aug, 2022
(Expiration: Mar, 2033)
GLEISS GROE SCHRELL UND PARTNER MBB
EP3016666B1 A marine oil formulation comprising reservatrol or derivatives thereof for use in treating, delaying and/or preventing alzheimer's desease SMARTFISH AS Aug, 2022
(Expiration: Jun, 2034)
NUTRICIA
EP3503867B1 Transparent cosmetic cleansing composition with improved rheological profil HENKEL AG AND CO KGAA Aug, 2022
(Expiration: Jul, 2037)
BONIBERGER
CRODA
EP3079714B1 Long lasting effect of new botulinum toxin formulations MEDY TOX INC Aug, 2022
(Expiration: Dec, 2034)
GALDERMA HOLDING
EP2379055B1 Method of making sustained release microparticles OAKWOOD LABORATORIES LLC Aug, 2022
(Expiration: Dec, 2029)
HOFFMANN EITLE
EP3409272B1 Pharmaceutical composition comprising eltrombopag olamine, reducing sugar, and polymeric binder ALFRED E TIEFENBACHER GMBH AND CO KG Aug, 2022
(Expiration: Apr, 2038)
BLLE DR
EP3283179B1 Solid skin care emulsion comprising solid and liquid lipids BEIERSDORF AG Aug, 2022
(Expiration: Mar, 2036)
HENKEL
EP3166636B1 Psgl-1 modulators and uses thereof SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Aug, 2022
(Expiration: Jul, 2035)
REGIMBEAU
EP3278665B1 Stable pharmaceutical composition and methods of using same AMARIN PHARMACEUTICALS IRELAND LTD Aug, 2022
(Expiration: Apr, 2030)
ELKINGTON AND FIFE
EP3061448B1 Composition containing eugenol as active ingredient for preventing or treating atopic dermatitis SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION Aug, 2022
(Expiration: Oct, 2034)
BEIERSDORF
EP3277718B1 Dosage regimen for anti-mif antibodies BAXALTA GMBH Aug, 2022
(Expiration: Mar, 2036)
SCORPIO
EP2260724B1 Process for preparing concentrate thickener compositions SIMPLYTHICK LLC Jul, 2022
(Expiration: Aug, 2022)
FRESENIUS KABI DEUTSCHLAND
EP1660022B1 Agent for colouring keratin fibres HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND SARL Jul, 2022
(Expiration: Jul, 2024)
HENKEL
EP2869813B1 Syringe NOVARTIS AG Jul, 2022
(Expiration: Jan, 2033)
DILG
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP3318255B1 Compositions and methods for treating stroke in a subject on concomitant statin therapy AMARIN PHARMACEUTICALS IRELAND LTD Jul, 2022
(Expiration: Jun, 2030)
COOKE
ELKINGTON AND FIFE
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
EP2863895B1 Tablet formulation comprising a peptide and a delivery agent NOVO NORDISK AS Jul, 2022
(Expiration: Jun, 2033)
CMS CAMERON MCKENNA NABARRO OLSWANG
GALENICUM HEALTH SLU
GENERICS UK
KRKA
MERCK SHARP & DOHME
SANDOZ
TEVA PHARMACEUTICAL INDUSTRIES
EP2775838B1 Aqueous antimicrobial composition containing coniferous resin acids PATOLAB OY Jul, 2022
(Expiration: Oct, 2032)
NORDIC BIOTECH GROUP
EP2482822B1 Orally administered corticosteroid compositions ADARE PHARMACEUTICALS INC Jul, 2022
(Expiration: Sep, 2030)
DR FALK PHARMA
EP1689360B1 Dry powder formulations JAGOTEC AG Jul, 2022
(Expiration: Nov, 2024)
NORTON HEALTHCARE
EP2399588B1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase IONIS PHARMACEUTICALS INC Jul, 2022
(Expiration: Jan, 2022)
GILEAD SCIENCES
EP2680711B1 Extensional viscosity to promote safe swallowing of food boluses NESTEC SA Jul, 2022
(Expiration: Mar, 2032)
FRESENIUS KABI DEUTSCHLAND
NUTRICIA
EP3388070B1 Extensional viscosity to promote safe swallowing of food boluses SOCIETE DES PRODUITS NESTLE SA Jul, 2022
(Expiration: Mar, 2032)
FRESENIUS KABI DEUTSCHLAND
NUTRICIA
EP3288561B1 Methods and pharmaceutical compositions comprising a sglt2 inhibitor for treating or improving erectile dysfunction BOEHRINGER INGELHEIM INTERNATIONAL GMBH Jul, 2022
(Expiration: Apr, 2036)
SANDOZ
EP2922533B1 Multi-day patch for the transdermal administration of rotigotine UCB BIOPHARMA SRL Jun, 2022
(Expiration: Nov, 2033)
AMW
HEXAL
EP2978446B1 Anti-cd33 antibody for use in treating alzheimer's disease GENERAL HOSPITAL CORP Jun, 2022
(Expiration: Mar, 2034)
ABBVIE
ALECTOR
KNIG SZYNKA TILMANN VON RENESSE
EP2410942B1 Curable zirconia adhesive compositions for dental restorations BISCO INC Jun, 2022
(Expiration: Mar, 2029)
RIECK
EP2861073B1 Soluble estradiol capsule for vaginal insertion THERAPEUTICSMD INC Jun, 2022
(Expiration: Jun, 2033)
RIECK
EP2207507B1 Once-a-day replacement transdermal administration of fentanyl ALZA CORP Jun, 2022
(Expiration: Oct, 2028)
HEXAL
EP2512436B1 Conditioning composition for hair KAO GERMANY GMBH Jun, 2022
(Expiration: Dec, 2030)
HENKEL
EP3088512B1 Use of placental stem cells for treating heart and circulatory diseases by promoting angiogenesis CELULARITY INC Jun, 2022
(Expiration: Apr, 2031)
D YOUNG
EP3148510B1 Liquid pharmaceutical composition FRESENIUS KABI DEUTSCHLAND GMBH Jun, 2022
(Expiration: May, 2035)
BIOGEN
SAMSUNG BIOEPIS UK
EP2614835B1 Vaccination with multiple clades of H5 influenza A virus SEQIRUS UK LTD Jun, 2022
(Expiration: Nov, 2028)
GLAXOSMITHKLINE BIOLOGICALS
EP2154244B1 Cell culture method using amino acid-enriched medium CHUGAI PHARMACEUTICAL CO LTD Jun, 2022
(Expiration: Apr, 2028)
HOFFMANN EITLE
NEUEFEIND
OETKE
STORZ
THOMAE
EP2651918B1 Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine NOVARTIS AG Jun, 2022
(Expiration: Dec, 2031)
GENERICS UK
TEVA PHARMACEUTICAL INDUSTRIES
EP3228299B1 Novel sunscreen composition with a reduced textile staining BEIERSDORF AG Jun, 2022
(Expiration: Mar, 2037)
LOREAL
EP1856051B1 Amorphous lercanidipine hydrochloride RECORDATI IRELAND LTD May, 2022
(Expiration: Feb, 2026)
ELKINGTON AND FIFE
FRESENIUS KABI DEUTSCHLAND
GLENMARK LIFE SCIENCES
HEUMANN PHARMA GENERICA
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
SANDOZ
STADA ARZNEIMITTEL
EP2328553B1 Corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract UNIVERSITY OF CALIFORNIA May, 2022
(Expiration: Nov, 2028)
AECHTER
EP2729151B1 Pharmaceutical composition, methods for treating and uses thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH May, 2022
(Expiration: Jul, 2032)
GENERICS UK
SANDOZ
EP3313874B1 Masking chimeric antigen receptor t cells for tumor-specific activation UNIVERSITY OF SOUTHERN CALIFORNIA USC May, 2022
(Expiration: Jun, 2036)
JAMES POOLE
EP3311791B1 Ethanol sunscreen composition with a reduced likelihood of discolouring textiles BEIERSDORF AG May, 2022
(Expiration: Oct, 2037)
BASF
EMIL KIESSLING
LOREAL
EP3336082B1 Cleavable lipids TRANSLATE BIO INC May, 2022
(Expiration: Jun, 2032)
DILG
GLAXOSMITHKLINE BIOLOGICALS
EP2752488B1 Antisense design ROCHE INNOVATION CENTER COPENHAGEN AS May, 2022
(Expiration: Nov, 2023)
IONIS PHARMACEUTICALS
EP2249847B1 Novel method for preparing extracts of ginkgo biloba IPSEN PHARMA SAS May, 2022
(Expiration: Feb, 2029)
DR WILLMAR SCHWABE
EP2709672B1 Compositions and methods for treating retinal diseases UNIVERSITY OF CALIFORNIA May, 2022
(Expiration: May, 2032)
RENEURON
EP2819669B1 New tiotropium formula containing propellant BOEHRINGER INGELHEIM INTERNATIONAL GMBH May, 2022
(Expiration: Feb, 2033)
HGF
EP3061454B1 Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC May, 2022
(Expiration: Jan, 2033)
KRKA
NISSAN CHEMICAL
EP2772500B1 Site-directed modification of FVIII BAYER HEALTHCARE LLC May, 2022
(Expiration: Nov, 2025)
MARKS & CLERK
EP2059258B1 Arginine wash in protein purification using affinity chromatography WYETH LLC May, 2022
(Expiration: Sep, 2027)
J A KEMP
STRAWMAN
EP2578228B1 Non-diffusive botulinum toxin causing local muscle paralysis, and purification method thereof MEDEXGEN INC May, 2022
(Expiration: May, 2031)
WCHTERSHUSER & HARTZ PATENTANWALTSPARTNERSCHAFT MBB
EP3354253B1 Use of diethylaminohydroxybenzoylhexylbenzoate in cosmetic sunscreening compositions BEIERSDORF AG May, 2022
(Expiration: Jan, 2038)
BASF
LOREAL
STADA ARZNEIMITTEL
EP3496657B1 Blank and method for producing a tooth replacement part SIRONA DENTAL SYSTEMS GMBH May, 2022
(Expiration: Aug, 2037)
IVOCLAR VIVADENT
EP2928496B1 Crispr-based genome modification and regulation SIGMA ALDRICH CO LLC May, 2022
(Expiration: Dec, 2033)
BASF
BAYER BAYER
COOLEY UK
GRUND
MATHYS & SQUIRE
PATENTANWLTE ISENBRUCK BSL HRSCHLER PARTG MBB
SCHLICH
VOSSIUS & PARTNER PATENTANWLTE RECHTSANWLTE MBB
EP2078460B1 Process for preparing concentrate thickener compositions SIMPLYTHICK LLC Apr, 2022
(Expiration: Aug, 2022)
FRESENIUS KABI DEUTSCHLAND
NESTEC
EP3320902B1 Methods for treating diseases using isoindoline compounds AMGEN EUROPE GMBH Apr, 2022
(Expiration: Mar, 2032)
TEVA PHARMACEUTICAL INDUSTRIES
EP3225233B1 Sodium chloride solution for drug reconstitution WYETH LLC Apr, 2022
(Expiration: Oct, 2026)
BIOVERATIV THERAPEUTICS
SWEDISH ORPHAN BIOVITRUM
EP2266549B1 Method of making particles for use in a pharmaceutical composition VECTURA LTD Apr, 2022
(Expiration: Jun, 2021)
GLAXO GROUP
EP3231805B1 Salt of pyrrolo[2,3-d]pyrimidine compound and novel polymorph of salt CRYSTAL PHARMATECH CO LTD Apr, 2022
(Expiration: Dec, 2035)
SAGITTARIUS CONSULTANTS
EP3421092B1 Anti-regurgitation composition preserving gut motility UNITED PHARMACEUTICALS SA Apr, 2022
(Expiration: May, 2034)
NUTRICIA
EP1586311B1 Melt extrusion of spherical multiparticulates EURO CELTIQUE SA Apr, 2022
(Expiration: Feb, 2025)
LEISTRITZ EXTRUSIONSTECHNIK
EP2234612B1 Composition for stimulating natural killer cell activity NUTRICIA NV Apr, 2022
(Expiration: Jan, 2029)
FRESENIUS KABI DEUTSCHLAND
EP2968434B1 C1-inh compositions for use in the prevention and treatment of hereditary angioedema (hae). SHIRE VIROPHARMA LLC Apr, 2022
(Expiration: Mar, 2034)
CSL BEHRING
OCTAPHARMA
EP3215173B8 Glycopeptide compositions XELLIA PHARMACEUTICALS APS Apr, 2022
(Expiration: Nov, 2035)
DF MP DRRIES FRANK MOLNIA & POHLMAN
EP3218065B1 Compositions and methods for the colouring keratinic fibres HENKEL AG AND CO KGAA Apr, 2022
(Expiration: Oct, 2035)
LOREAL
EP3137070B1 Krill oil preparations and their uses AKER BIOMARINE ANTARCTIC AS Apr, 2022
(Expiration: Apr, 2035)
RIMFROST
EP3219324B1 Application of dipeptide as ace enzyme activity inhibitor WITHYOU BIOTECHNOLOGY CO LTD Apr, 2022
(Expiration: Aug, 2034)
DANNER
EP3041581B1 Hair care composition comprising amino silicone, fatty alcohol and paraffin oil ALVES DIEGO M Apr, 2022
(Expiration: Sep, 2033)
HENKEL
EP3169308B1 Suspension compositions of cyclosporin a for subconjunctival and periocular injection ALLERGAN INC Mar, 2022
(Expiration: Jul, 2035)
GILL JENNINGS & EVERY
EP3449250B1 Methods and compositions for resolving components of a virus preparation UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL Mar, 2022
(Expiration: Apr, 2037)
DEFINITION
EP2978440B1 Treating fibrosis by inhibiting tl1a and diagnosing fibrosis by detecting il31ra CEDARS SINAI MEDICAL CENTER Mar, 2022
(Expiration: Mar, 2034)
STRAWMAN
EP2222335B1 Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same ZOETIS BELGIUM SA Mar, 2022
(Expiration: Nov, 2028)
MERIAL
EP3335736B1 Heterodimers of glutamic acid MOLECULAR INSIGHT PHARMACEUTICALS INC Mar, 2022
(Expiration: Nov, 2027)
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES FFENTLICHEN RECHTS UNIVERSITT HEIDELBERG
LEWIS SILKIN
POLSERVICE KANCELARIA RZECZNIKOW PATENTOWYCH SP Z OO
EP3106176B1 Aluminium compounds for use in therapeutics and vaccines VALNEVA AUSTRIA GMBH Mar, 2022
(Expiration: Dec, 2032)
SANOFI PASTEUR
EP2957552B1 Vilanterol formulations ARVEN ILAC SANAYI VE TICARET AS Mar, 2022
(Expiration: Jun, 2035)
BECK GREENER
GILL JENNINGS & EVERY
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
EP3241902B1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription UNIVERSITAET WIEN Mar, 2022
(Expiration: Mar, 2033)
DF MP DRRIES FRANK MOLNIA & POHLMAN
GRIEBLING
HGF
POHLMAN
TRUSCOTT
EP2460817B1 PCV2 immunogenic compositions and methods of producing such compositions BOEHRINGER INGELHEIM VETMEDICA INC Mar, 2022
(Expiration: Dec, 2025)
INTERVET
EP2861210B1 Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan MERRIMACK PHARMACEUTICALS INC Mar, 2022
(Expiration: Jun, 2033)
TEVA PHARMACEUTICAL INDUSTRIES
EP2734549B1 Monoclonal antibody against dog interleukin-31 ZOETIS SERVICES LLC Mar, 2022
(Expiration: Jul, 2032)
CEVA SANTE ANIMALE
EUROPEAN OPPOSITIONS
EP2943192B9 Methods of treating pancreatic cancer comprising paclitaxel and gemcitabine ABRAXIS BIOSCIENCE LLC Mar, 2022
(Expiration: Jan, 2034)
ACCORD HEALTHCARE
GENERICS UK
TEVA PHARMACEUTICAL INDUSTRIES
EP3034093B1 Compositions and methods of treating tumors UNIVERSITY OF PENNSYLVANIA PENN Mar, 2022
(Expiration: Mar, 2019)
F HOFFMANN LA ROCHE
EP2950816B1 The use of dna sequences encoding an interferon as vaccine adjuvants SCHWEITZER BIOTECH CO LTD Mar, 2022
(Expiration: Feb, 2034)
ZOETIS SERVICES
EP3114943B1 Non-allergenic food product NUTRICIA NV Mar, 2022
(Expiration: Aug, 2027)
SOCIT DES PRODUITS NESTL
EP2099453B1 Combination therapy of substituted oxazolidinones BAYER INTELLECTUAL PROPERTY GMBH Mar, 2022
(Expiration: Oct, 2027)
ABDI IBRAHIM ILAC SANAYI VE TICARET ANONIM SIRKETI
DENK PHARMA
GENERICS UK
HEXAL SANDOZ
INTERQUIM
KRAUS & WEISERT PATENTANWLTE PARTGMBB
MEDICHEM
STADA ARZNEIMITTEL
ZENTIVA GROUP
EP3240612B1 Methods of treating retinal diseases CELL CURE NEUROSCIENCES LTD Mar, 2022
(Expiration: Apr, 2035)
JAMES POOLE
MEISSNER BOLTE PATENTANWLTE RECHTSANWLTE PARTNERSCHAFT MBB
EP3102186B1 Donepezil compositions and method of treating alzheimer's disease FOREST LABORATORIES HOLDINGS LTD Mar, 2022
(Expiration: Feb, 2035)
BLLE DR
EP2611422B1 Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD Mar, 2022
(Expiration: Aug, 2031)
HGF
SANDOZ
TEVA UK
EP2957551B1 Dry powder formulations comprising vilanterol ARVEN ILAC SANAYI VE TICARET AS Mar, 2022
(Expiration: Jun, 2035)
BECK GREENER
GILL JENNINGS & EVERY
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
VECTURA
EP2674147B1 Method of preparing a hyaluronic acid-based gel including lidocaine HCl. ALLERGAN INDUSTRIE SAS Mar, 2022
(Expiration: Mar, 2029)
GALDERMA HOLDING
MERZ PHARMA
EP3461474B1 Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD Feb, 2022
(Expiration: Aug, 2031)
GENERICS UK
HGF
SANDOZ
TEVA UK
EP2293764B1 Ester compounds for use in personal care products LUBRIZOL ADVANCED MATERIALS INC Feb, 2022
(Expiration: Jun, 2029)
CRODA
EP2322153B1 Use of HIF Alpha stabilizers for enhancing erythropoiesis FIBROGEN INC Feb, 2022
(Expiration: Jun, 2024)
AKEBIA THERAPEUTICS
BAYER GMBHBAYER PHARMA AKTIENGESELLSCHAFTBAYER ANIMAL HEALTH
GLAXO GROUP
GLAXOSMITHKLINE UK
EP3192880B1 Nucleic acid agents for use in treating facioscapulohumeral dystrophy (fshd) LEIDS UNIVERSITAIR MEDISCH CENTRUM LUMC Feb, 2022
(Expiration: Aug, 2031)
REDDIE & GROSE
STRAWMAN
EP3397265B1 Protein-rich enteral nutritional composition containing a high proportion of caseinates EVEN SANTE INDUSTRIE SAS Feb, 2022
(Expiration: Dec, 2036)
LEIDESCHER
NUTRICIA
EP2478907B1 Compositions for treating cancer JANSSEN ONCOLOGY INC Feb, 2022
(Expiration: Aug, 2027)
ACCORD HEALTHCARE
ALFRED E TIEFENBACHER
ARISTO PHARMA
BIOGARAN
DR PFLEGER ARZNEIMITTEL
DR REDDYS LABORATORIES
FRESENIUS KABI DEUTSCHLAND
GENERICS UK
GLENMARK PHARMACEUTICALS EUROPE
HOFFMANN EITLE
KRKA
LABORATORIOS LON FARMA
MEDAC GESELLSCHAFT FR KLINISCHE SPEZIALPRPARATE
SANDOZ
STADA ARZNEIMITTEL
STRAWMAN
SUN PHARMACEUTICAL INDUSTRIES EUROPE
SYNTHON
TEVA PHARMACEUTICAL INDUSTRIES
TORRENT PHARMACEUTICALS
WELDING
ZENTIVA KS
EP3278809B1 Safe desmopressin administration SERENITY PHARMACEUTICALS LLC Feb, 2022
(Expiration: Jun, 2030)
FERRING
EP2898061B1 Probiotic compositions for the treatment of obesity and obesity-related conditions PROTHERA INC Feb, 2022
(Expiration: Aug, 2033)
COMPAGNIE GERVAIS DANONE
EP3018211B1 Antisense nucleic acids NIPPON SHINYAKU CO LTD Feb, 2022
(Expiration: Aug, 2031)
JAMES POOLE
SAREPTA THERAPEUTICS
EP2516473B1 Anionic polysaccharides functionalised with a derivative of hydrophobic acid ADOCIA SAS Feb, 2022
(Expiration: Dec, 2030)
HAMMER
EP2266422B1 Synergism of GOS and polyfructose NUTRICIA NV Feb, 2022
(Expiration: May, 2025)
SOCIT DES PRODUITS NESTL
EP2684565B1 Use of ulipristal acetate for treating uterine fibroids LABORATOIRE HRA PHARMA SAS Feb, 2022
(Expiration: Jan, 2029)
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
WITTKOPP
EP3173130B1 Sunscreen comprising titanium dioxide and octocrylene BEIERSDORF AG Feb, 2022
(Expiration: Nov, 2036)
DSM NUTRITIONAL PRODUCTS
EMIL KIESSLING
MIBELLE
STADA ARZNEIMITTEL
EP3173129B1 Sunscreen comprising titanium dioxide and ethylhexyl salicylate BEIERSDORF AG Jan, 2022
(Expiration: Nov, 2036)
DSM NUTRITIONAL PRODUCTS
EMIL KIESSLING
MIBELLE WANEK
STADA ARZNEIMITTEL
EP3260110B1 Aerosol hairspray product for styling and/or shaping hair PROCTER AND GAMBLE CO Jan, 2022
(Expiration: Dec, 2031)
BEIERSDORF
HENKEL
EP2766040B1 Pertuzumab, trastuzumab, docetaxel and carboplatin for the treatment of early-stage breast cancer F HOFFMANN LA ROCHE AG Jan, 2022
(Expiration: Oct, 2032)
DR H ULRICH DRRIES
DR REDDYS LABORATORIES
EUROPEAN OPPOSITIONS
GILL JENNINGS & EVERY
J A KEMP
KNIG SZYNKA TILMANN VON RENESSE
LEDL
POHLMAN
ROTH
EP3270871B1 Cosmetic compositions comprising a talc particulate IMERTECH SAS Jan, 2022
(Expiration: Mar, 2036)
IMI FABI
EP3354276B1 Compositions for the treatment of gastrointestinal inflammation MERITAGE PHARMA INC Jan, 2022
(Expiration: Nov, 2028)
AECHTER
DR FALK PHARMA
EP3395340B8 Rapid dissolution formulation of cinacalcet hcl AMGEN INC Jan, 2022
(Expiration: Sep, 2024)
ACCORD HEALTHCARE
AECHTER
BIOGARAN
GILLARD
GLENMARK PHARMACEUTICALS EUROPE
HAMM&WITTKOPP PATENTANWLTE PARTMBB
HGF
MAIWALD PATENTANWALTS UND RECHTSANWALTSGESELLSCHAFT
TEVA PHARMACEUTICAL INDUSTRIES